<DOC>
	<DOCNO>NCT02953847</DOCNO>
	<brief_summary>3-way cross-over single dose design evaluate bioavailability 2 rifampicin-containing FDCs v single drug comparator healthy volunteer</brief_summary>
	<brief_title>The Bioavailability Rifampicin ( FDCs ) Widely Used South Africa Treat Drug-susceptible ( TB )</brief_title>
	<detailed_description>In study 4- 2-drug FDCs ( intensive continuation phase respectively ) widely use within South African treatment program evaluate comparative bioavailability study single drug rifampicin product register South African Medicines Control Council . A three-way , single dose , cross-over study conduct 24 healthy volunteer</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Isoniazid</mesh_term>
	<criteria>Inclusion You need age 1855 year Have Body mass index ( BMI ) 1930 kg/m2 Weigh 45 kg Be nonsmoker Be find normal health history examination To normal blood urine test result If woman childbearing age , need prepared sexual intercourse , use safe form contraception , end study Exclusion You unable fully understand comply study procedure , requirement time commitment . Are currently enrol study evaluate drug , biologics device You TB , TB You abuse abused drug alcohol You , , drug allergy , severe asthma , active recurrent allergic disease You pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>